Free US stock insider buying and selling tracking with regulatory filing analysis for inside information on company health. We monitor corporate insider transactions because company officers often have the best understanding of their business prospects.
As of 2026-04-13, ProMIS Neurosciences Inc. Common Shares (ON) (PMN) is trading at $12.95, posting a 2.78% gain in the current session. This analysis covers key market context, technical support and resistance levels, and potential near-term scenarios for the clinical-stage biotech stock, with a focus on key levels market participants are monitoring in the current environment. No recent earnings data is available for PMN as of this date, so recent price action is primarily being driven by techni
What events could move ProMIS (PMN) Stock next | Price at $12.95, Up 2.78% - Certified Trade Ideas
PMN - Stock Analysis
4743 Comments
1711 Likes
1
Kamica
Active Contributor
2 hours ago
I feel like there’s a whole community here.
👍 77
Reply
2
Jayne
Returning User
5 hours ago
I read this and now I’m suspicious of everything.
👍 120
Reply
3
Mourya
Registered User
1 day ago
Momentum appears intact, but minor corrections may occur.
👍 89
Reply
4
Hammad
Loyal User
1 day ago
I don’t know what this is, but it matters.
👍 106
Reply
5
Amunra
New Visitor
2 days ago
This feels like something I’ll mention randomly later.
👍 52
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.